1. Membrane Transporter/Ion Channel
    Neuronal Signaling
  2. iGluR
  3. NMDA receptor antagonist 2

NMDA receptor antagonist 2 

Cat. No.: HY-136459
Handling Instructions

NMDA receptor antagonist 2 is a potent and orally active NR2B subtype-selective NMDA antagonist with an IC50 and a Ki of 1.0 nM and 0.88 nM, respectively. NMDA receptor antagonist 2 is used for the study of neuropathic pain and Parkinson’s disease.

For research use only. We do not sell to patients.

NMDA receptor antagonist 2 Chemical Structure

NMDA receptor antagonist 2 Chemical Structure

CAS No. : 875898-41-2

Size Stock
100 mg   Get quote  
250 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

NMDA receptor antagonist 2 is a potent and orally active NR2B subtype-selective NMDA antagonist with an IC50 and a Ki of 1.0 nM and 0.88 nM, respectively. NMDA receptor antagonist 2 is used for the study of neuropathic pain and Parkinson’s disease[1].

IC50 & Target

IC50: 1.0 nM;
Ki: 0.88 nM (NR2B subtype NMDA)[1]

In Vitro

NMDA receptor antagonist 2 leads to excellent potency at NR2B (Ki=0.88 nM) and selectivity over hERG binding (IP=20000 nM). NMDA receptor antagonist 2 is evaluated in a functional assay measuring Ca2+ flux in cells expressing recombinant NR1/NR2B receptors. Selectivity over the hERG-channel is evaluated in an MK-499-binding assay[1].
NMDA receptor antagonist 2 is highly potent in a functional assay using cells expressing NR2B (IC50=1.0 nM) and remains equipotent in a binding assay using a sample of homogenized human temporal cortex (Ki=0.81 nM). In an electrophysiology assay using NR2B receptors, Compound 22 shows full blockade of ion flux with KD=0.35 nM. Compound 22 also exhibits high levels of selectivity over NR2A (IC50=200 μM), hERG binding (IP=20 μM), α-adrenergic receptors based on Prazosin binding (IC50>100 μM), and CYP P450s including CYP3A4, 2C9, and 2D6[1].

In Vivo

In pharmacokinetic studies with higher species, NMDA receptor antagonist 2 shows excellent oral bioavailability (F=83%), half-life (T1/2=7.5 hours) and clearance (CL=3.6 mL/min/kg) in dog. And it exhibits moderate clearance (CL=12 mL/min/kg) and oral bioavailability (F=17%) in rhesus, the half-life (T1/2) is 1.5 hours[1].
In a rat pharmacokinetic study, NMDA receptor antagonist 2 shows oral bioavailability (F=23 %), half-life (T1/2=0.7 hours) and clearance (CL=24 mL/min/kg), the receptor occupancy ED50 with oral administration is 4.8 mg/kg in rat[1].
In the spinal nerve ligation model of neuropathic pain in rats, surgical ligation of two lumbar nerves in the spinal column induces a state of mechanical allodynia[1].
NMDA receptor antagonist 2 (oral administration; 3-30 mg/kg) inhibits tactile allodynia in a dose-dependent manner after oral administration at 10 and 30 mg/kg. It produces an average improvement in the maximal possible effect of 15% (3 mg/kg), 41% (10 mg/kg), and 69% (30 mg/kg) compared to vehicle treated animals[1].
NMDA receptor antagonist 2 (oral administration; 3-30 mg/kg) is efficacious in an acute rodent model of Parkinson’s disease. Haloperidol (HY-14538) is administered at a dose previously shown to elicit an acute cataleptic response in rats, compound 22 reduces catalepsy scores in a dose-dependent manner, producing average improvements of 34% (3 mg/kg), 86% (10 mg/kg), and 92% (30 mg/kg) when it compares to vehicle group[1].

Molecular Weight

375.43

Formula

C₂₀H₂₁N₇O

CAS No.

875898-41-2

SMILES

CC1=CC=C(CC2=NOC([[email protected]@H]3C[[email protected]@H](NC4=C5C(NN=C5)=NC=N4)CC3)=N2)C=C1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Solvent & Solubility
In Vivo:
  • 1.

    Compound?22?is dissolved in 1% methylcellulose and orally administered via gavage[1].

References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Keywords:

NMDA receptor antagonist 2NMDA receptor antagonist2NMDA receptor antagonist-2iGluRIonotropic glutamate receptorsCNSneuropathic painParkinson’sdiseaseRhesusOrally BioavailableSpinalnerveligationSNLinjuryInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number *

 

Organization name *

Country or Region *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product name:
NMDA receptor antagonist 2
Cat. No.:
HY-136459
Quantity:
MCE Japan Authorized Agent: